Martingale Asset Management »

Puma Biotechnology shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Puma Biotechnology (PBYI) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Puma Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Puma Biotechnology held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Puma Biotechnology by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $206k 25k 8.11
2014-12-31 $214k 1.1k 189.88

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
Abbvie (ABBV)
Exxon Mobil Corp
Cisco Systems (CSCO)
Visa (V)
Merck & Co (MRK)

View all positions for Martingale Asset Management

Top funds holding Puma Biotechnology

Acorn Capital Advisors
BlackRock
American Century Companies
Acadian Asset Management
Renaissance Technologies
Vanguard Capital Management
Vanguard Portfolio Management
LSV Asset Management
Dimensional Fund Advisors
Geode Capital Management
O'shaughnessy Asset Management
State Street Corporation
Kennedy Capital Management
Bridgeway Capital Management
Comprehensive Portfolio Management

View all funds holding Puma Biotechnology